# Everolimus

## Afinitor 5mg

| 藥物代碼 | OAFI |
| :--- | :--- |
| 適應症 | Treatment of postmenopausal women w/ advanced hormone receptor positive & HER-2 negative breast cancer in combination w/ exemestane after failure of treatment w/ letrozole or anastrozole. Progressive neuroendocrine tumors of pancreatic origin \(PNET\) w/ unresectable, locally advanced or metastatic disease. Advanced renal cell carcinoma \(RCC\) after failure of treatment w/ sunitinib or sorafenib. |
| 副作用 | Stomatitis, infections, rash, fatigue, diarrhea, decreased appetite, hyperglycemia, dyspnea, pneumonitis, hypercholesterolemia, increased AST & ALT, anemia, leukopenia, thrombocytopenia, lymphopenia, hypertriglyceridemia, decreased K. |
| 禁忌 | Hypersensitivity to everolimus or other rapamycin derivatives. |
| 藥物保存方式 | 室溫 |
| 用法用量 | \[Advanced Breast cancer, hormone receptor-positive, HER2-negative; Advanced Neuroendocrine tumors \(GI, lung, or pancreatic origin\); Advanced Renal cell cancer \(RCC\)\] 10 mg orally once daily, continue treatment until disease progression or unacceptable toxicity |
| 肝功能異常 | 需 調 整 劑 量  - 輕度肝功能不全\(Child-Pugh A\)- 建議劑量為每日7.5 毫克；若無法忍受，劑量可調降至5 毫克。 - 中度肝功能不良\(Child-Pugh B\)- 建議劑量為每日5 毫克；若無法忍受，劑量可調降至2.5 毫克。 - 重度肝功能不良\(Child-Pugh C\)- 若期望的益處超出風險，可給予每日2.5 毫克，但不可超過此劑量。 |
| 腎功能異常 | 無需調整劑量 |
| 懷孕用藥危分級 | 儘量避免 |
| 孕期用藥建議 | N/A |
| 附帶說明 | N/A |
| 哺乳期用藥建議 | Human Data Suggest Potential Toxicity |
| 附帶說明 | N/A |
| 注射劑給藥建議途徑 | N/A |
| 乾粉稀釋液 | N/A |
| 輸注點滴液 | N/A |
| IVP 用法建議 | N/A |
| IVD 用法建議 | N/A |
| 注意事項 | N/A |

